End-Tidal Oxygen for Intubation in the Emergency Department

Recruiting N/A Interventional Study
Critical Illness Hypoxia Respiratory Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
1,400 (estimated)
Sponsor
Sydney Local Health District · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Rapid Sequence Intubation (RSI) is a high-risk procedure in the emergency department (ED). Patients are routinely preoxygenated (given supplemental oxygen) prior to RSI to prevent hypoxia during intubation. For many years anaesthetists have used end-tidal oxygen (ETO2) levels to guide the effectiveness of preoxygenation prior to intubation. The ETO2 gives an objective measurement of preoxygenation…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. The patient is located in the ED resuscitation bay of the participating centre. 2. The planned procedure is orotracheal intubation using a laryngoscope and RSI technique with preoxygenation for patients who are spontaneously breathing. 3. The patient is deemed to be at a high…
Contacts

Matthew Oliver, MBBS

+61410188680

matthew.oliver@health.nsw.gov.au

CONTACT

Naomi Derrick

+61457240478

naomi.derrick@health.nsw.gov.au

CONTACT